By Bob L : NEWS AS I SEE IT! By MATTHEW PERRONE, AP Business WriterWASHINGTON – The Food and Drug Administration has allowed drugs for cancer and other diseases to stay on the market even when follow-up studies showed they didn’t extend patients’ lives, say congressional investigators.A report due out Monday from the Government Accountability Office also shows that the FDA has never pulled a drug off the market due to a lack of required follow-up about its actual benefits — even when such inform
Originally posted here:
GAO: FDA fails to follow up on unproven drugs
